Cocrystal Pharma Inc (COCP)
1.495
+0.06
(+4.55%)
USD |
NASDAQ |
Apr 18, 16:00
1.47
-0.02
(-1.67%)
After-Hours: 20:00
Cocrystal Pharma Total Liabilities (Quarterly): 4.875M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 4.875M |
September 30, 2023 | 1.924M |
June 30, 2023 | 1.597M |
March 31, 2023 | 3.172M |
December 31, 2022 | 1.273M |
September 30, 2022 | 1.738M |
June 30, 2022 | 2.99M |
March 31, 2022 | 1.792M |
December 31, 2021 | 1.843M |
September 30, 2021 | 1.586M |
June 30, 2021 | 2.669M |
March 31, 2021 | 1.793M |
December 31, 2020 | 1.737M |
September 30, 2020 | 3.039M |
June 30, 2020 | 3.423M |
March 31, 2020 | 2.41M |
December 31, 2019 | 2.823M |
September 30, 2019 | 2.692M |
June 30, 2019 | 2.489M |
March 31, 2019 | 2.471M |
December 31, 2018 | 1.674M |
September 30, 2018 | 13.27M |
June 30, 2018 | 13.68M |
March 31, 2018 | 16.58M |
December 31, 2017 | 16.03M |
Date | Value |
---|---|
September 30, 2017 | 22.26M |
June 30, 2017 | 22.30M |
March 31, 2017 | 22.54M |
December 31, 2016 | 22.56M |
September 30, 2016 | 53.08M |
June 30, 2016 | 53.32M |
March 31, 2016 | 55.82M |
December 31, 2015 | 56.64M |
September 30, 2015 | 69.41M |
June 30, 2015 | 72.61M |
March 31, 2015 | 79.90M |
December 31, 2014 | 252.63M |
September 30, 2014 | 7.657M |
June 30, 2014 | 6.911M |
March 31, 2014 | 12.56M |
December 31, 2013 | 10.49M |
September 30, 2013 | 18.05M |
June 30, 2013 | 13.01M |
March 31, 2013 | 12.17M |
December 31, 2012 | 10.82M |
September 30, 2012 | 8.335M |
June 30, 2012 | 13.00M |
March 31, 2012 | 13.77M |
December 31, 2011 | 10.32M |
September 30, 2011 | 10.88M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.273M
Minimum
Dec 2022
4.875M
Maximum
Dec 2023
2.414M
Average
2.41M
Median
Mar 2020
Total Liabilities (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 5.72M |
Palatin Technologies Inc | 24.94M |
iBio Inc | 24.82M |
Theriva Biologics Inc | 15.52M |
Ampio Pharmaceuticals Inc | 2.376M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 31.26M |
Shareholders Equity (Quarterly) | 26.38M |